Organization
Suzhou Alphamab
4 clinical trials
Clinical trial
An Open, Randomized, Active-comparator-controlled, Multicenter Study to Assess the Efficacy and Safety of Different Doses of KN060 for the Prevention of Venous Thromboembolism in Patients Undergoing Unilateral Total Knee Arthroplasty.Status: Recruiting, Estimated PCD: 2025-12-15
Clinical trial
An Open, Multicenter, Dose Escalation Study To Evaluate The Safety, Tolerability, Pharmacokinetics, And Pharmacodynamics Of Multiple Subcutaneous (SC) Doses of KN057 in Subjects With Hemophilia A or B, With or Without InhibitorsStatus: Recruiting, Estimated PCD: 2024-02-28
Clinical trial
A Randomized, Open-label Study to Evaluate the Efficacy and Safety of KN057 Injection Prophylaxis in Patients With Hemophilia A or B With InhibitorsStatus: Recruiting, Estimated PCD: 2025-10-15
Clinical trial
A Randomized, Double-blind and Placebo-controlled Phase I Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of KN056 in Healthy ParticipantsStatus: Recruiting, Estimated PCD: 2023-12-22